BJUI Mini Reviews - Development of Growth Inhibitory Agents in Urological and Other Malignancies
This review looks at anticancer drug development, like drug development in other medical disciplines, which typically proceeds in a fashion classically divided into phase I, II, III and IV studies.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
